Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease

European Respiratory Journal

Volumn 28, Issue 3, 2006, Pages 472-478

  Zervou, M I ^a   Tzortzaki, E G ^a   Makris, D ^a   Gaga, M ^b   Zervas, E ^b   Economidou, E ^b   Tsoumakidou, M ^a   Tzanakis, N ^a   Milic Emili, J ^c   Siafakas, N M ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Chronic bronchitis; Cigarette smoking; Genetic susceptibility; Genomic instability; Somatic mutation; Sputum

Indexed keywords

ASPARTIC ACID; GLYCINE; MICROSATELLITE DNA; SERINE;

ADULT; AGED; ARTICLE; ASTHMA; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 2P; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DNA DETERMINATION; DNA EXTRACTION; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; PREDICTION; PRIORITY JOURNAL; SPUTUM ANALYSIS;

ADULT; AGED; ASTHMA; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DNA; FEMALE; GENETIC MARKERS; HUMANS; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 33751264590     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00127305     Document Type: Article

References (53)

1. Meyers DA, Larj NJ, Lange L. Genetics of asthma and COPD. Similar results for different phenotypes. Chest 2004; 126: 105S-110S, 159S-161S.
2. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS paper. Eur Respir J 2004; 23: 932-946.
3. 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15: 132-140.
4. Molfino AN. Genetics of COPD. Chest 2004; 125: 1929-1940.
5. Kauffmann F, Kleisbauer JP, Cambon-De-Mouzon A, et al. Genetic markers in chronic air-flow limitation. A genetic epidemiologic study. Am Rev Respir Dis 1983; 127: 263-269.
6. Lomas DA, Silverman EK. Genetics of chronic obstructive pulmonary disease. Respir Res 2001; 2: 20-36.
7. Diagnosis and classification. In: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02-3659. pp. 67-80. http://www.ginasthma.com/Guidelineitem.asp?l1=2&12=1&intId=83 Date updated: October 28, 2004. Date accessed: June 30 2006.
8. Collaborative Study on the Genetics of Asthma. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nature Genetics 1997; 15: 389-392.
9. Osmond W, Cookson C. Asthma genetics. Chest 2002; 121: 7-13.
10. Spandidos DA, Ergazaki M, Hatzistamou J, et al. Microsatellite instability in patients with chronic obstructive pulmonary disease. Oncol Rep 1996; 3: 489-491.
11. Charlesworth B, Sniegowski P, Stephan W. The evolutionary dynamics of repetitive DNA in eukaryotes. Nature 1994; 371: 215-220.
12. Field D, Wills C. Abundant microsatellite polymorphism in Saccharomyces cerevisiae, and the different distributions of microsatellites in eight prokaryotes and S. cerevisiae, results from strong mutation pressures and a variety of selective forces. Proc Natl Acad Sci USA 1998; 95: 1647-1652.
13. Martin-Farmer J, Janssen GR. A downstream CA repeat sequence increases translation from leadered and unleadered mRNA in Escherichia coli. Mol Microbiol 1999; 31: 1025-1038.
14. Bertoni F, Codegoni AM, Furlan D, Tibiletti MG, Capella C, Broggini M. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. Genes Chromosomes Cancer 1999; 26: 176-180.
15. Martin P, Makepeace K, Hill SA, Hood DW, Moxon ER. Microsatellite instability regulates transcription factor binding and gene expression. Proc Natl Acad Sci USA 2005; 102: 3800-3804.
16. Field JK, Kiaris H, Howard P, et al. Microsatellite instability in squamous cell carcinoma of the head and neck. Br J Cancer 1995; 71: 1065-1069.
17. Loeb LA, Christians FC. Multiple mutations in human cancers. Mutat Res 1996; 350: 279-286.
18. Froudarakis M, Sourvinos G, Fournel P, et al. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer. Chest 1998; 113: 1091-1094.
19. Samara K, Zervou M, Siafakas NM, Tzortzaki EG. Microsatellite DNA instability in benign lung diseases. Respir Med 2006; 100: 202-211.
20. Fujisawa T, Ikegami H, Kawaguchi Y, et al. Length rather than a specific allele of dinucleotide repeat in the 5′ upstream region of the aldose reductase gene is associated with diabetic retinopathy. Diabet Med 1999; 16: 1944-1947.
21. Detorakis ET, Sourvinos G, Tsamparlakis J, et al. Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. Br J Ophthalmol 1998; 82: 1324-1328.
22. Hatzistamou J, Kiaris H, Ergazaki M, et al. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun 1996; 225: 186-190.
23. Siafakas NM, Tzortzaki EG, Sourvinos G, et al. Microsatellite DNA instability in COPD. Chest 1999; 116: 47-51.
24. Paraskakis E, Sourvinos G, Passam F, et al. Microsatellite DNA instability and loss of heterozygosity in bronchial asthma. Eur Respir J 2003; 22: 951-955.
25. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 2003; 5: Suppl. 16, 5-40.
26. Holz O, Kips J, Magnussen H. Update on sputum methodology. Eur Respir J 2000; 16: 355-359.
27. Tsoumakidou M, Tzanakis N, Siafakas NM. Induced sputum in the investigation of airway inflammation of COPD. Respir Med 2003; 97: 863-871.
28. Chrysofakis G, Tzanakis N, Kyriakoy D, et al. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004; 125: 71-76.
29. Tsoumakidou M, Tzanakis N, Kyriakou D, Chrysofakis G, Siafakas NM. Inflammatory cell profiles and T-lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma. Clin Exp Allergy 2004; 34: 234-340.
30. Siafakas NM, Tzortzaki EG. Few smokers develop COPD. Why? Respir Med 2002; 96: 615-624.
31. Kips JC, Peleman RA, Pauwels RA. Methods of examining induced sputum: do differences matter? Eur Respir J 1998; 11: 529-533.
32. Anderson GP, Bozinovski S. Acquired somatic mutations in the molecular pathogenesis of COPD. Trends Pharmacol Sci 2003; 24: 71-76.
33. Chizhikov VV, Chikina SIu,, Tatosian AG, Chuchalin AG, Zborovskaia IB. Development of chronic obstructive pulmonary disease correlates with mini- and microsatellite locus instability. Genetika 2003; 39: 694-701.
34. Amelung PJ, Postma D, Panhuysen CI, Meyers DA, Bleecker ER. Susceptibility loci regulating total serum IgE levels, bronchial hyperresponsiveness, and clinical asthma map to chromosome 5q. Chest 1997; 111: 77S-78S.
35. Nickel R, Wahn U, Hizawa N, et al. Evidence for linkage of chromosome 12q15-q24.1 markers to high total serum IgE concentrations in children of the German Multicenter Allergy Study. Genomics 1997; 46: 159-162.
36. Barnes KC, Neely JD, Duffy DL, et al. Linkage of asthma and total serum IgE concentration to markers on chromosome 12q: evidence from Afro-Caribbean and Caucasian populations. Genomics 1996; 7: 41-50.
37. Sandford AJ, Pare PD. The genetics of asthma. The important questions. Am J Respir Crit Care Med 2000; 161: S202-S206.
38. Dizier MH, Besse-Schmittler C, Guilloud-Bataille M, et al. Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med 2000; 162: 1812-1818.
39. Samara KD, Tzortzaki EG, Zervou MI, et al. Magnetic MicroBeads sputum cell sorting in obstructive airway disease. Eur Respir J 2004; 24: Suppl. 48, 469s.
40. National Center for Biotechnology Information. Summary of Maps in UniSTS. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unists. Date last updated: June 28, 2006. Date last accessed: June 30 2006.
41. Wistuba II, Mao L, Gazdar AF. Smoking molecular damage in bronchial epithelium. Oncogene 2002; 21: 7298-7306.
42. Vassilakis DA, Sourvinos G, Spandidos DA, et al. Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2000; 162: 1115-1119.
43. Crapo JD. Oxidative stress as an initiator of cytokine release and cell damage. Eur Respir J 2003; 22: Suppl. 44, 4s-6s.
44. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003; 124: 1373-1380.
45. Rahman I. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: anti-oxidant therapeutic targets. Curr Drug Targets Inflamm Allergy 2002; 1: 291-315.
46. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22: 672-688.
47. Tsoumakidou M, Tzanakis N, Chrysofakis G, Siafakas NM. Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbation of chronic obstructive pulmonary disease. Chest 2005; 127: 1911-1918.
48. Rennard SI. Cigarette smoke in research. Am J Respir Cell Mol Biol 2004; 31: 479-480.
49. Lee SH, Chang DK, Goel A, et al. Microsatellite instability and suppressed DNA repair enzyme expression in rheumatoid arthritis. J Immunol 2003; 170: 2214-2220.
50. Coughlin P, Nicholl J, Sun J, Salem H, Bird P, Sutherland GR. Chromosomal mapping of the human proteinase inhibitor 6 (PI6) gene to 6p25 by fluorescence in situ hybridization. Genomics 1995; 26: 431-433.
51. Strik MC, Wolbink A, Wouters D, et al. Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with β-tryptase monomers. Blood 2004; 103: 2710-2717.
52. Trapani JA, Sutton VR. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol 2003; 15: 533-543.
53. Kashi Y, King D, Soller M. Simple sequence repeats as a source of quantitative genetic variation. Trends Genet 1997; 13: 74-78.